ConvaTec Group Plc (CNVVF) Stock | CNVVF Stock Price & Analysis

Feed

CNVVF

ConvaTec Group Plc CNVVF · OTC

$3.22 +0.00% (+$0.00)

Summary

58 / 100 · Bulios Score

Valuation 40Growth 74Profitability 64Quality 46Debt 56Stability 79

What speaks for it

Earnings per share grew by 42% a year over the last 3 years.
It bought back its own shares for $333.3M in the last fiscal year, 5.4% of its market value.

What to watch

The share price is above the Bulios Fair Price.
It pays out more in dividends than it earns: 116% of profit.
It missed profit estimates 5 times in the last 8 quarters.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Is it expensive?

Looks expensive

Bulios Fair Price

Current price $3.22

P/E today 49.6 2.0% lower

5-year average P/E 50.7

P/E today 49.6

Medical - Instruments & Supplies industry median

Unlock fair price

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 49.6 USD for 1 USD of yearly profit. Over the last five years it was 50.7 USD on average.

Valuation in detail

Is it growing?

Yes, fast

Revenue (USD)

2.0B

2.1B

2.3B

2.5B

2.6B

2.7B

2021202220232024202520262027

Diluted EPS (USD)

$0.06

$0.03

$0.06

$0.09

$0.20

$0.23

2021202220232024202520262027

Analyst estimate

Revenue grew by 5.6% a year over 5 years. Over the last 3 years it grew by 6.4% a year. For the next fiscal year analysts expect revenue to grow by 2.4%. Earnings per share grew by 42% a year over the last 3 years.

Growth in detail

Does it make money?

Reasonably

Where 100 USD of revenue goes

Cost of sales 45 USD
Research and development 4.9 USD
Sales and administration 34 USD
Taxes and other 11 USD
Net profit 5.0 USD

Net profit, industry median (Medical - Instruments & Supplies) 8.4 USD

Out of every 100 USD of revenue, 5.0 USD is left as net profit.

Profitability in detail

Is it financially healthy?

Debt is a burden

Cash and short-term investments $98.9M

Debt $1.74B

Free cash flow over 12 months $192.0M

Repaying all its debt would take 9.1 years of free cash flow. Its debt is larger than its cash.

Financial health in detail

Does it pay a dividend?

Small, at risk

0.05

0.06

20212022202320242025

Yield: 2.34%
Paid out of profit: 116%
Raised in a row: 1 year

You receive $0.08 per share a year. The payout is more than the company can comfortably cover.

Dividends in detail

What do analysts expect?

No coverage

No analyst covers this stock.

Analysts in detail

What does it earn on?

By product

The company reports no revenue by product.

By region

The company reports no revenue by region.

Segments in detail